ABSTRACT: To more fully understand the molecular mechanisms responsible for variations in binding affinity with antibody maturation, we explored the use of site specific fluorine labeling and 19 F nuclear magnetic resonance (NMR). Several single-chain (scFv) antibodies, derived from an affinitymatured series of anti-hen egg white lysozyme (HEL) mouse IgG1, were constructed with either complete or individual replacement of tryptophan residues with 5-fluorotryptophan ( 5F W). An array of biophysical techniques was used to gain insight into the impact of fluorine substitution on the overall protein structure and antigen binding. SPR measurements indicated that 5F W incorporation lowered binding affinity for the HEL antigen. The degree of analogue impact was residue-dependent, and the greatest decrease in affinity was observed when 5F W was substituted for residues near the binding interface. In contrast, corresponding crystal structures in complex with HEL were essentially indistinguishable from the unsubstituted antibody.
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ABSTRACT: To more fully understand the molecular mechanisms responsible for variations in binding affinity with antibody maturation, we explored the use of site specific fluorine labeling and 19 F nuclear magnetic resonance (NMR). Several single-chain (scFv) antibodies, derived from an affinitymatured series of anti-hen egg white lysozyme (HEL) mouse IgG1, were constructed with either complete or individual replacement of tryptophan residues with 5-fluorotryptophan ( 5F W). An array of biophysical techniques was used to gain insight into the impact of fluorine substitution on the overall protein structure and antigen binding. SPR measurements indicated that 5F W incorporation lowered binding affinity for the HEL antigen. The degree of analogue impact was residue-dependent, and the greatest decrease in affinity was observed when 5F W was substituted for residues near the binding interface. In contrast, corresponding crystal structures in complex with HEL were essentially indistinguishable from the unsubstituted antibody. 19 F NMR analysis showed severe overlap of signals in the free fluorinated protein that was resolved upon binding to antigen, suggesting very distinct chemical environments for each 5F W in the complex. Preliminary relaxation analysis suggested the presence of chemical exchange in the antibody−antigen complex that could not be observed by X-ray crystallography. These data demonstrate that fluorine NMR can be an extremely useful tool for discerning structural changes in scFv antibody−antigen complexes with altered function that may not be discernible by other biophysical techniques.
A ntibodies are of considerable interest to structural biologists as extremely useful, naturally occurring models for designing and studying specific, tight-binding protein− protein interactions. Immunoglobulins share a very similar structural fold that provides a stable platform for supporting remarkable sequence plasticity while retaining function (e.g., immune surveillance and foreign molecule recognition). X-ray crystallographic structures of numerous antibody−antigen complexes are available, 1−4 and much has been learned about the importance of shape complementarity, hydrogen bonding, salt bridge formation, solvent interactions, and the hydrophobic environment at the binding interface. However, structures of uncomplexed antibodies are comparatively rare. 5 The free antibody is expected to be much more flexible, particularly in the complementarity-determining region (CDR) loops; this conformational heterogeneity is likely a major contributing factor in the difficulty in obtaining crystals suitable for diffraction. In those studies in which both the free and complexed immunoglobulin structures are available, it is clear that the static representations afforded by crystallography alone often do not fully explain differences in specificity or binding affinity that are observed. 6 This is of particular importance when attempting (1) to understand adaptation and eluding of host defenses by certain pathogens or (2) to develop antibody therapeutics with increased efficacy. There is a clear need for methods that can provide novel detailed site specific information about structure, chemical environment, and flexibility that can supplement and support X-ray crystallography data and provide new insights into altered function introduced by mutations.
Besides in silico experiments using molecular dynamics simulations, there are very few methods currently available for measuring flexibility in proteins. Kinetics and thermodynamics can provide solution state indirect evidence for dynamics on the macro level. Arguably, nuclear magnetic resonance (NMR) is the only technique that offers structural, chemical, and dynamic information at the atomic level under biologically relevant (and adaptable) solution conditions. 7−9 Recently, 19 F NMR has advanced considerably as a tool for the investigation of biological molecules, 10 particularly in the solid state for membrane proteins. 11 Replacement of naturally occurring amino acids (e.g., phenylalanine and tryptophan) with a modified amino acid that can act as a 19 F NMR active probe offers the potential to provide a specific and sensitive measure of changes in environment and flexibility in solution before and after the binding event. Combined with highresolution structural data, kinetics, and thermodynamic measurements, this information can be used in the engineering of proteins with very high affinity and specific recognition by directing decisions on specific mutations. As an NMR probe, 19 F has distinct advantages in biological investigations. F-labeled molecules do not suffer from high biological background. Together, these two attributes can permit lower concentrations of protein to be used, which can be critically important when investigating large complexes with moderate to low solubility. As a probe of changes in the local environment, the large chemical shift range associated with the 19 F shielding parameter allows for better resolution of differences in proteins containing multiple reporting groups. These changes in environment should be particularly evident for 19 F probes situated at a binding interface of an antibody− antigen complex. During formation of the complex, changes in the surrounding electric field, short-range contacts, and hydrogen bonding can all potentially affect the observed chemical shift for any 19 F nucleus. The atomic radii of 1 H and the 19 F nucleus are very similar; therefore, when fluorine is substituted on the indole ring of tryptophan, it is not expected to significantly change its shape or space requirements; it is considered a mild structural perturbation when incorporated into proteins. However, the strongly electronegative fluorine nucleus can dramatically alter the charge distribution and dipole moment of an aromatic system compared to hydrogen. The potential utility of the technique is extended by the commercial availability of numerous 19 F-labeled amino acids, nucleotides, and sugars that can be biosynthetically incorporated into proteins and/or used for the solid-phase synthesis of small peptides, proteins, RNA, DNA, and polysaccharides. Tryptophan analogues are particularly useful in investigations of larger proteins because the relative abundance of tryptophan in protein sequences is usually much lower than that of other amino acids. This makes assignment of peaks after biosynthetic incorporation less challenging. In addition, antibody−antigen complexes can also reveal information about local changes in flexibility and chemical exchange by measuring NMR relaxation parameters that are influenced by dipole−dipole and chemical shift anisotropy relaxation mechanisms. 12 Over the past two decades, we and others have studied the HyHEL series of mouse IgG1 antibodies to explore the biophysical and structural changes that accompany affinity maturation to a specific antigen epitope (HEL).
13−32 Crystal structures of representative intermediates along this affinity maturation pathway in complex with HEL have been determined at high resolution and have revealed that binding is enhanced by additional hydrophobic effects and/or interactions and improved shape complementarity. 33 Along with the solid state data, thermodynamic and kinetic data in solution have enhanced our basic understanding of these biologically relevant interactions. Notably, we discovered that when studied by surface plasmon resonance (SPR), some of these complexes follow kinetics of binding much more complex than simple 1:1 association models. 34 Despite this wealth of information, there are several somatic mutations in this series whose physical bases for contributing to changes in binding remain unexplained using these techniques. Furthermore, a comprehensive understanding of a loss of affinity or crossreactivity to various antigenic mutants remains elusive. This study explores the potential of using 19 F NMR of novel scFv antibody analogues, along with X-ray, circular dichroism (CD), and SPR analysis, to reveal new information regarding these interactions. It was thought that the use of various solution techniques may help further illuminate the details of the antibody−antigen binding interactions that may not be resolved in the solid state structures.
In this report, we demonstrate the feasibility and utility of 19 F NMR in 1) characterizing the interaction between an intermediate-affinity IgG1 antilysozyme antibody (HyHEL10) 18, 35, 36 and its antigen and 2) further refining our understanding of physical effects contributing to the binding free energy that are not completely revealed by X-ray analysis alone. We biosynthetically incorporated 19 F-labeled tryptophan into a scFv fragment from HyHEL10 13 and analyzed the fluorine spectra of both the free and antigen-complexed analogue-incorporated antibody.
■ MATERIALS AND METHODS
Sample Preparation. Chemical reagents were purchased from Sigma-Aldrich (St. Louis, MO) unless otherwise indicated. The antigen hen egg white lysozyme (HEL) (Worthington Biochemicals, Lakewood, NJ) was further purified using gel filtration chromatography prior to use. The plasmid containing the wild-type HyHEL10 scFv (hereafter simply termed scFv) antibody construct 13 under control of the T7-lac promoter was transformed into BL21(DE3) cells (EMD Biosciences, San Diego, CA) and expressed as inclusion bodies at 37°C in LB medium. For complete 5-fluorotryptophan ( 5F W) incorporation (this scFv termed 5F W-scFv), the plasmid was transformed into the CT19 tryptophan-auxotrophic cell line. 37 For the assignment of NMR peaks to specific tryptophan residues, each tryptophan residue in the scFv sequence was mutated in turn to phenylalanine via site-directed mutagenesis using the Quikchange II Mutagenesis kit (Stratagene, La Jolla, CA). Experimental details of the expression, isolation, and purification of these constructs are outlined in the Supporting Information, including a listing of forward primer sequences used for introducing phenylalanine substitutions (Table S1) .
SPR Measurements. Rate constants for affinity determination and thermodynamic parameters were determined using a Biacore 2000 SPR instrument and BIAevaluation (GE Healthcare Bio-Sciences, Piscataway, NJ). Samples were passed over a CM5-dextran chip immobilized with amine-coupled HEL to provide surfaces that ranged from 80 response units (RU) to 150 RU. Previous work has shown that the interaction of this family of antibodies with HEL results in complex two- step binding kinetics that are best evaluated using a series of different injection times. 38 The SPR experimental protocol consisted of four analyte-inject (association) times of 10, 25, 60, and 120 min, followed by a 2 h dissociation phase with HBS buffer. Data from the corresponding three sensorgrams were corrected using a reference flow cell prepared from the same chip that had been produced using the same amine coupling protocol without protein. These reference-corrected sensorgrams were then pooled for global analysis using a two-step model. Two separate experiments using different concentrations of scFv (18−55 μM) were considered as replicates for statistical analysis.
Thermal Stability Assessment of Proteins. Aggregation due to denaturing for each protein sample was monitored by an increase in absorbance (scattering) at 330 nm ( Figure S1 of the Supporting Information). Each sample to be tested was incubated between 25 and 37°C. At different time intervals, aliquots were removed and diluted to 50 μM prior to measurement of the absorbance at 330 nm. The period of abrupt change in the absorbance profile was used to assess the maximal temperature that could be used for NMR experiments.
X-ray Crystallography. Crystals of scFv and 5F W-scFv were grown by the vapor diffusion method in hanging drops. The complexes with HEL were concentrated to 7.5 mg/mL (scFv) or 2.5 mg/mL ( 5F W-scFv) in HBS buffer and mixed with a well solution containing 0.2 M sodium citrate and 40% PEG400 in 0.1 M Tris buffer (pH 8.5). Small needle-shaped crystals were grown and used for data collection. Diffraction data extending to 2.3 Å resolution for 5F W-scFv and to 2.7 Å for scFv were recorded at 100 K on beamlines 21-ID-D and 22-BM, respectively, at the Advanced Photon Source (Argonne, IL). For 5F W-scFv, the oscillation range was 0.5°with an exposure time of 0.5 s and a wavelength of 0.979 Å. A Mar-300 detector was used. For scFv, the oscillation range was 0.5°with an exposure time of 2 s and a wavelength of 1 Å. A Mar-225 detector was used. The structure of 5F W-scFv was determined by molecular replacement with PHASER using the structure of a complex of scFv with lysozyme (Protein Data Bank entry 2dqj) as the search model. The structure was initially refined with Phenix, and the refinement was completed with REFMAC. Refinement of scFv was conducted with REMAC using the final coordinates of 5F W-scFv as an initial model. The statistics of refinement for the two structures are listed in Table S2 of the Supporting Information. Structures have been deposited in the Protein Data Bank (http://www.rcsb.org/pdb/home/home. do) as entries 2ZNW (scFv) and 2ZNX ( 5F W-scFv). 19 F NMR. Samples for NMR were prepared immediately prior to use to minimize the possibility of aggregation. HBS-G [10 mM HEPES, 150 mM NaCl, 3 mM EDTA, and 3% (v/v) glycerol (pH 7.4)] was used in preparation of all NMR samples, and glycerol was used in the sample buffer to improve stability and solubility of the sample. Previous work with these antibodies in our lab showed that this level of glycerol does not significantly impact antigen binding and was therefore adequate for the purposes of unambiguously assigning peaks. To each sample was added 10% D 2 O as a lock solvent. The scFv antibody labeled with 5F W was concentrated to 350 μM by centrifugation using a prewashed Amicon Ultracel 10000 MWCO spin filter (VWR, West Chester, PA). This was transferred to a clean 1.5 mL centrifuge tube and clarified as necessary at 18000g for 10 min at room temperature prior to being loaded into the NMR tube. For titration experiments, HEL was prepared from crystallized, lyophilized powder to a final concentration of 2 mM to limit dilution of the scFv sample during titration. Sample solutions were clarified by centrifugation just prior to use. Phenylalanine mutants were prepared in the same way, but two of these mutants (W36F and W103F) exhibited reduced solubility during concentration. 19 F NMR spectra were recorded using a Varian (Palo Alto, CA) INOVA 500 spectrometer operating at 470 MHz using a specially designed H-F probe with a single channel dual-tuned to both 1 H and 19 F (Nalorac). All NMR experiments were performed at 30°C unless otherwise noted (vide infra). The 19 F resonances were referenced to trifluoroacetic acid (TFA) at −76.55 ppm as an external standard. Because of the low concentration, experiments were conducted for a minimum of 5000 increments to obtain spectra with a sufficient signal-tonoise ratio (S/N). Most spectra of the complex were run overnight with standard one-dimensional pulse sequences. Longitudinal (T 1 ) and transverse (T 2 ) relaxation time measurements were taken using inversion−recovery and Carr−Purcell− Meiboom−Gill (CPMG) spin echo pulse sequences, respectively, taken from the Varian Chempack sequence library within VNMRJ version 2.2d. Relaxation times were calculated using macros defined in the Varian software. The lengths for the 90°a nd 180°pulses in the T 2 experiments were 14 and 28 μs, respectively. The time between consecutive 180°pulses (τ cp ) ranged from 0.12 to 1 ms for the inspection of the variation of T 2 with τ cp .
■ RESULTS AND DISCUSSION
Incorporation of 5F W into scFv and Characterization. Several fluorinated and mutant scFv proteins were prepared (for detailed experimental procedures and forward primer sequences, see the Supporting Information and Table S1 ). A total of 14 proteins were prepared; these are listed in Table 1: wild-type scFv, "fully" fluorinated protein 5F W-scFv (all six tryptophans replaced with 5F W), six 5F W-scFv analogues in which each of the six 5F W residues was individually replaced with a single phenylalanine residue [designated 5F W(PheX)-scFv, where X is the residue number of the mutation], and six nonfluorinated proteins in which each tryptophan was individually mutated in turn to a phenylalanine [designated (PheX)-scFv, where X is the residue number of the mutation]. The phenylalanine mutants were prepared to aid in both the assignment of the fluorinated residues by NMR and the assessment of the effect each fluorinated tryptophan had on the binding of the scFv to HEL antigen (vide infra).
With the exception of the light chain mutant 5F W(Phe35)-scFv, all antibodies were successfully refolded and purified to yield stable soluble material. The 5F W(Phe35)-scFv antibody showed weakened binding to the anion exchange column, eluting at a much lower concentration of NaCl during the gradient. This mutant also exhibited significant amounts of soluble protein aggregate that eluted in the void volume during gel filtration chromatography indicative of incomplete or poorly refolded scFv. The tryptophan at this position is invariant in IgG sequences and is likely critical to IgG folding and stability. All purified antibodies were functional and bound to HEL as assessed by SPR (see below), with the exception of W. No other peaks that corresponded to other fluorinated species could be identified; therefore, the level of incorporation was presumed to be 100%.
Crystal Structures. As in our previous studies, 33 we examined the crystal structures of both the wild-type scFv fragment and its fully fluorinated analogue in complex with HEL. Although uncomplexed single-chain antibody fragments can be analyzed by crystallography, 39, 40 this remains difficult because of the inherent flexibility of these constructs. The uncomplexed scFv prepared here could not be analyzed, but moderate-resolution structures were obtained for both the wildtype and 5F W-incorporated scFv complexes with HEL. Figure  1A shows a depiction of the antibodies in complex with HEL highlighting the tryptophan residues in the scFv that were modified with fluorine. The crystallographic data and statistics are listed in Table S2 of the Supporting Information. Two antibody molecules and two lysozyme molecules were present in the crystal asymmetric unit.
The overall quality of the models, as assessed by PROCHECK 41 and by other parameters such as R factors, meets the acceptable criteria for structures determined with comparably limited resolution of the diffraction data. 42, 43 All main chain atoms and most of the side chains fit well into the 2F o − F c electron density map. The quality of the F o − F c electron density map ( Figure 1B) is also quite good, defining their conformation in an unambiguous manner.
Superposition of the two independent antibody molecules in the wild-type structure results in a root-mean-square deviation (rmsd) of 0.65 Å for 220 Cα atoms. Simultaneous superposition of the two complexes of the wild-type and fluorinated antibody resulted in an rmsd of 0.34 Å for 700 Cα atoms, whereas a similar comparison of only "A" molecules from the asymmetric unit of the antibodies yielded an rmsd of 0.24 Å for 221 Cα atoms. The latter value is within the range of structure accuracy expected at this resolution, whereas superposition of two crystallographically independent molecules includes structural changes due to crystal packing.
All tryptophan residues in the wild-type antibody and 5F W residues in the variant are very well ordered. When the wildtype and fluorinated complexes are superimposed as discussed above, the side chains of these residues are almost completely superimposable, with the largest deviation between corresponding atoms not exceeding 0.3 Å. Because that variation is very similar to the accuracy of the structures themselves, we can conclude that modification of the tryptophan side chains did not lead to any significant changes in the static structures of these proteins. In Figure 1C , the three panels show expanded views along with the charge density depiction of 5F W residues 34, 94, and 98 (red) in an overlay with the wild-type complex (green) and include nearby residues from the antigen (gray). These residues are at or near the interface of the antibody− antigen complex. These orientations showcase some of the potential charge−charge interactions introduced with the fluorinated amino acids. The electronegative fluorine atom causes a distinct change to the dipole moment and charge distribution of the tryptophan indole ring 44 that could result in either positive or negative contributions to binding. In this case, the effect is detrimental because the 5F W-scFv−HEL association has a lower affinity than the wild-type complex (vide infra).
Circular Dichroism and UV. A comparison of the UV and CD spectra of scFv and 5F W-scFv is shown in Figure 2 . The small red shift of the absorbance maximum that is typically characteristic for 5F W-modified proteins was also observed for our fully fluorinated analogue, 5F W-scFv 45 ( Figure 2A ). The CD spectrum of 5F W-scFv also showed small but significant shifts relative to its unfluorinated counterpart, indicating a change in secondary structure with 5F W incorporation. The wild-type scFv displays a more typical β-like signature; the spectrum of 5F W-scFv was more disordered, with the negative band at 218 nm slightly blue-shifted with a lower ellipticity. Hence, Figure 2B suggests that slightly different conformations are preferred in solution for the wild-type and fluorinated scFv analogues. This slight change in the overall conformation is translated to the complex structures with HEL, as shown by the comparison of the CD data for wild-type and 5F W-scFv complexes ( Figure 2C ). Despite the results that show virtually indistinguishable HEL structures, this is likely not the case for complex structures in solution (vide infra).
Binding Kinetics Using Biacore SPR. Previous work using SPR has shown that the interaction of this family of antibodies with HEL results in complex two-step binding kinetics (eq 1) that are best evaluated using a series of different injection times. 
where AB is the intermediate encounter complex and AB* is the final docked conformation. This protocol derives from the observation that the kinetics of dissociation of the antibody from bound antigen on the surface of the chip is dependent on the length of time used for association. The longer the injection time, the more stable the complex. Furthermore, the forward rate constant for the second step (k 2 ) is concentrationindependent. These two observations are consistent with a model in which there is a structural change in the antibody (A)−antigen (B) complex over the time course of association that in turn affects the observed off rate. The antibody (A) and antigen (B) form an initial encounter complex (AB) followed by an additional conformational rearrangement resulting in the more stable docked conformer (AB*). One experimental SPR cycle can sample only a specific population during the course of this time-dependent structural change. Therefore, it is necessary to measure dissociation after several different times of association to better represent the two bound states in the final global fit. A summary of the binding constants derived from SPR kinetic experiments for all samples is presented in Table 1 . When 5F W is incorporated into each of the six tryptophan positions in scFv, the affinity is as much as 31 times lower than that of the same antibody without 5F W substitution (Table 1 , entries 1 and 2, and Figure 3 ). Despite the antibody still having strong nanomolar affinity for antigen, this large decrease in affinity with fluoro analogue incorporation was surprising. Upon comparison of the affinities of the phenylalanine mutants, an increase in the level of binding with this substitution relative to that with 5F W at that position indicates the degree of impact that the analogue is having on binding to HEL. The 5F W-(Phe36)-scFv mutant (entry 10) showed binding very similar to that of 5F W-scFv, indicating that substitution of 5-fluorotryptophan at this position had very little impact on binding. Both the 5F W(Phe94)-scFv (entry 6) and 5F W-(Phe98)-scFv (entry 12) mutants had higher binding affinity than 5F W-scFv and, therefore, negatively impacted binding to HEL. With positions 94 and 34, the mutation to phenylalanine at that position in the wild-type protein [(Phe94)-scFv and (Phe34)-scFv, entries 5 and 7, respectively] had very little impact on binding (∼2-fold); however, at position 98, the same phenylalanine substitution [(Phe98)-scFv, entry 11] resulted in a binding affinity that was very similar to that observed with the same mutation and 5F W incorporated at the other five positions [ 5F W(Phe98)-scFv, entry 12]. It can be expected that with 5F W(Phe98)-scFv, the phenylalanine substitution would have a similar negative impact on binding; this must be taken into account when judging the relative impact of 5F W at position 98. Essentially no effect on binding was observed upon replacement of position 103 with phenylalanine (entry 13), whereas mutation of W103 to Phe in the fully fluorinated protein (entry 14) had a small positive effect on binding of HEL by SPR.
Optimal Conditions for and Peak Assignments from 19 F NMR Experiments. To determine the optimal temperature for NMR experiments, the thermal stability of 5F Wincorporated antibody samples was determined by measuring absorbance changes (scattering) at 330 nm as a result of unfolding and aggregation ( Figure S1 of the Supporting Information). This was performed at concentrations comparable to those that could be expected for the NMR experiments (approximately 300 μM). At 37°C, the 5F W-scFv antibody was not stable over the 16 h incubation period and showed significant signs of aggregation after 2 h. As the temperature is lowered, stability increases, and at 30°C, the antibody shows very little indication of aggregation. This was the temperature chosen to perform all NMR experiments.
A total of six fluorine peaks were expected for the modified antibody corresponding to the six tryptophans present in its primary sequence (and later confirmed by mass spectrometry) that were replaced with 5F W. For the uncomplexed 5F W-scFv, a series of broad, semiresolved peaks were observed at 30°C (Figure 4 ). Varying conditions produced limited success. For resonance assignment, each tryptophan was mutated to phenylalanine in the 5F W-scFv construct, resulting in five 19 F peaks; however, like the wild-type protein, each mutant in its free (uncomplexed) form was not fully resolved, and in some cases, not all peaks were observed (representative examples are shown in Figure 4B−D) . When 5F W-scFv was titrated with HEL, a gradual separation of all six peaks was observed and all were clearly distinguishable at a 1:1 ratio ( Figure 5 ). Importantly, three peaks showed large W on antibody−antigen interaction. SPR sensograms of scFv (black) and 5F W-scFv (red). The antigen was immobilized on a carboxymethyl dextran chip surface via amine coupling, and binding (response) was monitored as the antibody was injected over this surface at a flow rate of 10 μL/min. Curves represent comparisons of one time course for injection with a group of four different injection times. WscFv and the Phe mutants with those of their complexes, most peaks were unambiguously assigned to a specific 5F W. As expected, the spectrum of these mutant complexes showed only five peaks with the missing peak corresponding to the phenylalanine-substituted position ( Figure 6A ). Only five mutants (see Table 1 ) were used, because of the aforementioned folding and stability issues with the W35F construct. Assignments for residues 38, 94, 98, and 103 were relatively straightforward. The W36F spectrum was difficult to interpret, as the resolution and sensitivity ( Figure 6A ) were lower than expected, making this and the W35F residue assignment tentative. The solid and tentative assignments, based on the collected data, are shown in the bottom spectrum of Figure 6A . Also notable was the fact that in the single-Phe mutants of 5F WscFv, there were distinctive chemical shift changes in some of the remaining fluorine signals. A diagnostic example is W98F mutant 5F W(Phe98)-scFv: In this mutant, the 5F W94 signal experiences a significant upfield shift because of the change to phenylalanine. When position 98 is a tryptophan, the indole NH and H2 protons are within 4.6 Å of the 5F W94 fluorine atom ( Figure 6B) . A change from indole to phenyl could adjust the aromatic ring such that 5F W94 is shielded relative to 5F WscFv. There are also noticeable downfield shifts for 5F W94 in the 5F W103F mutant. The fact that these two residues are not in the proximity of each other suggests a more "global" conformational adjustment in response to the 5F W103F mutation, again affecting 5F W94. The results show that interfacial residues W94 and W98 are critical determinants of the structural integrity of the complex. 19 F Relaxation Analysis. To qualitatively define the dynamic environment of the fluorinated tryptophans and possible chemical exchange phenomena, the T 1 and T 2 relaxation times were calculated for each of the six 5F W residues in the 5F W-scFv−HEL complex. 46, 47 Values of both spin−lattice (T 1 ) and spin−spin (T 2 ) relaxation are in the ranges that have been observed for fluorinated amino acids incorporated into protein complexes of a similar size. 12 The majority of T 1 values are slightly over 1 s, with the exception of that of W35 (795 ms). As shown in Table  2 and Figure 6A , it was not possible to differentiate between tryptophans 35 and 36 because the W35F mutant was not sufficiently stable for NMR analysis. However, the lower T 1 may be a clue about the identity of W35 because the 5F W side chain of this residue is buried between strands of two β-sheets of the scFv structure in the solid state, whereas W36 is more exposed to the solvent (vide infra).
Biochemistry
As stated above, it is possible to detect exchange phenomena and to potentially assign specific processes by adjusting parameters in the CPMG sequence. According to relationships (derived from the original Bloch equations) postulated by Luz and Meiboom 48, 49 and further refined by Allerhand and Gutowsky 50 along with Carver and Richards, 46 as the 180°i nterpulse delay is increased, there is a corresponding increase in the T 2 relaxation rate:
where T 2°i s the value of T 2 at which no exchange takes place, P a and P b are the fractional proportions of the molecules in states a and b, respectively, and τ cp is the interval between 180°p ulses. It is assumed that chemical exchange is limited to two sites and the spin echo decay in the experiment is exponential. Only a handful of studies have utilized this concept in attempts to define various aspects of exchange phenomena, and they have primarily dealt with small molecule ligand binding. 48, 49, 51 One specific report utilized 19 F NMR to define a chemical exchange process related to different small drug molecules bound to a 5F W-labeled ionotropic glutamate receptor, GluR2. 52 According to eq 2, T 2 decreases as the interpulse delay τ cp is increased; this was observed for a specific 5F W residue in ref 52 . In the case of the 5F W-scFv complex with HEL, there is a dramatic increase in T 2 values with an increasing τ cp . In addition, all 5F W residues experience this increase in T 2 and in approximately equal amounts. This suggests a global exchange phenomenon occurring on the time scale of the interpulse delay that (1) is not localized near one or two specific residues and (2) serves to depress the relaxation rate rather than increase it as suggested by eq 2. The suggestion here is that the motion that is sampled during the CPMG experiment is one in which the fluorine atoms experience "less ability" to interact with other spins, possibly indicating some momentary loss of well-defined tertiary structure. However, this proposal would stand in contrast with the fact that although the 5F W-scFv−HEL complex has a binding affinity lower than that of the wild type, there remains relatively strong binding (binding constants still in the nanomolar range). In addition, after the initial "jump" in relaxation time, the last point suggests perhaps a modest decrease in T 2 , which more accurately fits the theory and eq 2. As only three data points were collected because of the mild loss of stability (and hence sensitivity) with time, an accurate depiction of the actual exchange process occurring during these experiments could not be developed. These data point to the complexity of the changes occurring in our system in solution.
Relevant Effects of Incorporation of 19 F into HyHEL10 scFv. We had prepared mutant scFv constructs in which all tryptophans are replaced with 5F W as well as those with singlePhe replacements leaving five fluorine atoms for the purposes of assignment. In addition, nonfluorinated mutants in which each tryptophan was replaced with Phe in the wild-type antibody were prepared. A comparison of the ΔΔG values calculated from the kinetically derived (SPR) binding constants is useful in defining the contributions that each individual fluorine-containing residue makes to the overall antigen− antibody binding of the fully fluorinated antibody, 5F W-scFv. An illustration of this analysis is shown in Figure 7 and Table 3 . The value of ΔΔG for 5F W-scFv relative to scFv is 1.97 kcal/ mol. If the ΔΔG from 5F W-scFv where one tryptophan is mutated is calculated and subtracted from 1.97, a qualitative measure of the contribution of each 5F W on that specific residue is obtained. As seen in Table 3 , major differences exist for W94, W98, and W34. Several lines of data (vide supra) confirm the influence of W94 and W98. W34 is positioned at the edge of a β-strand on the heavy chain that begins a loop connecting another strand of a β-sheet. The integrity of that loop may be compromised by mutation of this residue and in turn affect the formation of proper secondary structure, which weakens binding. Furthermore, the W34 indole makes contact with Asp32 ( Figure 1C ). Asp32 in turn is involved in two important salt bridges with antigen hot-spot residues Arg21 and Lys97. A change in charge distribution in the neighboring W34 may influence this charge−charge interaction between Asp21 and the hot-spot residues. In addition, W98 makes an energetically important contact with HEL; it is involved in both hydrogen bonding and a salt-link network. 28 The partial charge change at that position due to the modified dipole moment of the fluorinated indole ring in 5F W, together with the overall change in hydrophobicity with this tryptophan analogue, may explain the observed change in function. Finally, Figure 6A depicts the detrimental effect that particular substitutions have on both the sensitivity of the NMR spectra and broadening of peaks; some virtually disappear, viz., the W103 signal in the W36F spectrum. Close examination of the structures reveals that W36 is sandwiched between two β-sheets, with W103 positioned on a long loop connecting two strands of one of the sheets of the sandwich. There is an obvious disruption in the interfacial contacts by a W36F mutation, compromising the structural integrity of much of the heavy chain. This in effect may cause W103 to be much more mobile, resulting in a severely broadened peak that cannot be observed under the conditions of the experiment. For this work, we were interested in comparing differences in interactions between a model scFv and its fluorinated analogues and HEL, within the context of the modified antibody. Evidence that these fluoroindole derivatives do not significantly impact the structure of the complex was found for the solid state. While CD experiments suggested some small changes in structure for the free antibody, SPR measurements clearly indicate that there is a distinct change in function for the antibody analogue that is highly site-dependent. Our results support the observation that these analogues can affect function, so care must always be taken when extrapolating results to the wild-type protein. In addition, as there did not seem to be any obvious deleterious steric or hydrogen bonding influences of fluorine incorporation, the aforementioned change in the dipole moment could explain the lower overall affinity and possible exchange phenomena in this system. Incorporation of 4-fluorotryptophan ( 4F W) residues, whose indole dipole moment is similar to that of unmodified indole, into scFv resulted in an affinity with HEL (by SPR) that was similar to that of the wild-type protein (data not shown). Although the level of incorporation of 4F W was lower than that of 5F W and hence no high-resolution structures were obtained, the data do suggest that the 5F W dipole moment is the critical property that affects the properties of binding to the antigen. Thus, although irreplaceable in structural biology, X-ray crystal structures are often insufficient for unambiguously assessing the impact of changes introduced by specific analogues in a protein.
■ CONCLUSION
19 F NMR data obtained from incorporating 5-fluorotryptophan into a scFv antibody have provided valuable insights into the environment around these reporting groups at the binding interface and the changes that occur from the free antibody. It also illustrates that the function of the residue may influence the impact of a 19 F substitution when it is done in isolation. To the best of our knowledge, this is the first report of intrinsic labeling of an antibody with NMR active fluorinated amino acids for use in NMR analysis. These data can be used to better interpret the physical impact of somatic and antigenic mutations and better inform engineering efforts to modify binding to mutants. Future studies should include looking at other mutations at the interface targeted around the reporting groups, using other fluorotryptophan probes to compare and contrast their possible impact on binding, and assessing the introduction of additional tryptophan positions into the antibody sequence at the binding interface to act as new reporting groups.
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Page S4 All purification steps for refolded antibody were conducted at room temperature. Concentrated,
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refolded scFv was loaded onto a DEAE Sepharose Fast-flow column (GE Healthcare BioSciences, Piscataway, NJ). Sample was eluted with a linear gradient (0-500 mM NaCl over 3 column volumes). Soluble scFv was the last protein to elute and corresponding fractions were pooled, concentrated, and applied to a Superdex 75 HR gel filtration column (GE Healthcare Bio-Sciences, Piscataway, NJ) equilibrated with HBS buffer (10mM HEPES, 150mM NaCl, 2mM EDTA, pH 7.4). This buffer was used for sample storage and all subsequent experiments unless otherwise indicated. Purity of sample was assessed using SDS-PAGE and elution profiles from gel filtration chromatography. Additional verification of sample purity, level of 5F W incorporation and proper mutation was obtained using an Agilent 1100 LC/MS mass spectrometer (Quantum Analytics, Foster City, CA). Concentration was determined by measured absorbance at 280 nm. Absorbance scans were used to qualitatively assess analog incorporation prior to refolding based on the red-extended absorption spectrum of 5F W 1 .
Site-directed mutagenesis. For assignment of NMR peaks to specific tryptophan residues, each tryptophan residue in the scFv sequence was mutated in turn to phenylalanine via site-directed mutagenesis using the Quikchange II Mutagenesis kit (Stratagene, La Jolla, CA). The forward primers (Oligonucleotide Synthesis Laboratory NCI-Frederick, Frederick, Maryland) used to provide the appropriate amino acid replacements are listed in supporting information Table S1 .
All mutations were verified by sequencing (DNA Sequencing Laboratory NCI-Frederick, Frederick, Maryland). Each of these phenylalanine mutants was expressed and purified as described previously. Two samples of each phenylalanine mutant were prepared. One expressed with 5F W and one without, so that we could assess the impact each phenylalanine mutant had on binding to HEL and compare that to the corresponding effect of having 5F W at that position. 
S4

